{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:03:39Z","timestamp":1775228619194,"version":"3.50.1"},"reference-count":0,"publisher":"Therapeutic Guidelines Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Prescr"],"DOI":"10.18773\/austprescr.2021.010","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T21:12:57Z","timestamp":1614805977000},"page":"64-66","source":"Crossref","is-referenced-by-count":0,"title":["New drug: Defibrotide for hepatic veno-occlusive disease"],"prefix":"10.18773","volume":"44","member":"39051","published-online":{"date-parts":[[2021,3,4]]},"container-title":["Australian Prescriber"],"original-title":[],"link":[{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/defibrotide-for-hepatic-veno-occlusive-disease.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:18:20Z","timestamp":1775225900000},"score":1,"resource":{"primary":{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/defibrotide-for-hepatic-veno-occlusive-disease.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.18773\/austprescr.2021.010","relation":{},"ISSN":["1839-3942"],"issn-type":[{"value":"1839-3942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]}}}